Clinical drug trials are a booming business and private equity wants in on the action

  • 📰 dallasnews
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 71%

Business News News

Business Business Latest News,Business Business Headlines

Investment firms are pouring billions into one of the health care industry’s more hidden niches - clinical trials.

Still, most trial sites are physician practices that don’t consistently perform studies,“Independent sites are being purchased by private equity, and they’re moving into larger site groups of 30, 40, and then their game plan is to roll that up into a business and then sell it again,” said Linda Moore Schipani, CEO of Clinical Research Associates, a Nashville-based company that worked on COVID vaccine trials for AstraZeneca, Novavax, and Pfizer. “That’s kind of the endgame.

A research center in Brownsville, Texas — a stone’s throw from the U.S.-Mexico border and where 95% of the population is Hispanic or Latino — is one of several where it is partnering with Pfizer to boost patient diversity. Similarly, he said, Headlands is moving the McAllen site’s operations to Brownsville “because it had a larger population of trained personnel.”

“The thing is speed, getting it to market. With a bigger network, you get that speed,” Torrence said on the podcast. “The writing to me was on the wall that either I get some outside investment and scale up myself, or kind of listen to these guys and see if maybe now would be the right time to exit.”

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

This is one of those things that is clearly a bad idea

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 18. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Saudi crown prince set to invest in Credit Suisse's new investment bankSaudi Arabia’s crown prince and a U.S. private-equity firm run by Barclays' former chief executive are reportedly among investors preparing to invest $1 billion or more into Credit Suisse’s new investment bank. Can anyone say money down a rat hole. Name the firm and how it benefits them to do such a thing …please I am not sure if the investment decisions of a Murderer matter so much, nevertheless, it is clear that Credit Suisse will not fail so it is a bargain. $CS is cheap.
Source: MarketWatch - 🏆 3. / 97 Read more »

WSJ News Exclusive | Credit Suisse’s Investment Bank Spinoff Attracts Saudi Crown PrinceSaudi Arabia's crown prince and a U.S. private-equity firm run by Barclays PLC's former chief executive are among those preparing to invest in Credit Suisse's upstart investment bank Saudi Arabia's murderer satrap you mean? People in Iran are fighting for the regime change not only for mandatory hijab! Don't let the Islamic Republic play with u & don't let ur news agencies spread regime's lies They're still the same monsters who run the whole system It's IranRevolution2022 MahsaAmini مهسا_امینی
Source: WSJ - 🏆 98. / 63 Read more »

After FTX debacle, what should we know before making an investment?Diversity is the key to making sure your portfolio stays on track. Don't invest in things with no intrinsic value,, like computer code as a glaring example..
Source: njdotcom - 🏆 282. / 63 Read more »